Efficacy and Safety of ICP-332 Versus Placebo in Participants With Moderate to Severe Plaque Psoriasis

Abroad (travel likely)RecruitingPHASE2

Conditions

Plaque Psoriasis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Shanghai Dermatology Hospital, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Yuling Shi, M.D.) · shiyuling1973@126.com · 021-36803154

Study leads

Yuling Shi
Principal Investigator
Shanghai Dermatology Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis

Plaque Psoriasis

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Fountain Valley, United States

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis

Moderate to Severe Plaque Psoriasis

Abroad (travel likely)RecruitingPHASE3

Fountain Valley, United States · Los Angeles, United States

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Birmingham, United States

A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis

Plaque Psoriasis

Abroad (travel likely)RecruitingPHASE3

Chula Vista, United States · Fountain Valley, United States